53 h. ago BPCL Q1 Review: PL Capital Upgrades The Stock To 'Hold' On Strong Marketing Margins

PL Capital upgrades the stock from 'Reduce' to 'Hold' rating and revises target price based on 1.5x FY27 price/book value as benign oil prices may raise marketing margins further.

Politics

3 d. ago Aavas Financiers Upgraded To 'Buy' By IDBI Capital Despite AUM Growth Slowdown In Q1; Sees 30% Upside

IDBI Capital has upgraded Aavas Financiers from 'Hold' to 'Buy' and revises target price, citing an 18% stock correction and an expected 30% return from current levels.

Economics

3 d. ago KNR Constructions Gets 'Buy' Call From IDBI Capital Despite Execution Woes In Q1

IDBI Capital upgrades KNR Constructions from Hold to Buy and revises target price, implying a 21% upside

Politics

3 d. ago Zydus Lifesciences Q1 Review: Systematix Maintains 'Hold', Revises Target Price

Systematix revised target price stands at Rs 1,020, based on 25x FY27 EPS, and retain a Hold on the stock.

Events

5 d. ago Siemens Q3 Review: Motilal Oswal Retains 'Netural' Stance On The Stock, Cuts Target Price

Motilal Oswal retains Neutral rating on the stock with a revised target price of Rs 3,300.

Events

1 week ago Gujarat Fluorochemicals Shares Upgraded To 'Hold' By PL Capital Post Q1 Results

Following the recent price correction and commercialization of R32 ahead of schedule, PL Capital upgrades GFL to 'Hold' and revises target price

Science

1 week ago DLF's Privana Launch Lifts Q1 Sales; But Collections Disappoint, Says Motilal Oswal Maintaining 'Buy'

Motilal Oswal reiterates Buy rating with a revised target price of Rs 1,005

Economics

1 week ago Alembic Pharma Q1 Review: Dolat Capital Maintains 'Add', Revises Target Price

Dolat Capital maintains 'Accumulate' rating on Alembic Pharma and revises target price.

Events

1 week ago Vedanta's Q1 Performance Moderated Due To Commodity Prices, Says Systematix Maintaining 'Buy'

Systematix values Vedanta FY27 EV/Ebitda SoTP with a revised target price of Rs 510/share, implying an upside of 20% from current market price.

Economics

4 w. ago LTIMindtree Shares: Dolat Capital Revises Rating To 'Add' Post Inline Q1 Results

Given some recent surge in price, Dolat Capital revises rating to 'Accumulate'.

Politics